TrialDiabetic medicine : a journal of the British Diabetic Association2025
Cost-effectiveness of fenofibrate versus standard care for reducing the progression of diabetic retinopathy: An economic evaluation based on data from the LENS trial.
Graham Scotland et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.